
In a major announcement, the Competition Commission of India (CCI) has said it will accept Amazon’s proposal to fully acquire Prione Business Services.
Prione, a technology provider that offers small businesses in India’s growing digital economy a suite of services, is also the owner of Cloudtail, one of the biggest and most profitable retailers on Amazon India, reported Techcrunch.
With the go-ahead now in place, Amazon will acquire the entire stake of Narayana Murthy-backed Catamaran Ventures in the company. The company was originally established in 2014 as a joint venture between Amazon and Catamaran.
“Commission approves acquisition of Prione Business Services Private Limited by Amazon Asia-Pacific Resources Private Limited,” said CCI in a tweet on Wednesday.
Senior Amazon India executives are expected to hold a meeting on the matter this week, according to the sources.
Amazon announced its plans to take full control of Prione Business Services in December of 2021, subject to the requisite regulatory approvals. On August 09, 2021, the partners had announced their decision to not continue the JV beyond the end of its current term in May 2022.
Under India’s current regulations it remains unclear whether Cloudtail will be able to continue its operations as a seller on Amazon’s marketplace, as India prohibits foreign direct investment (FDI) in inventory-based models for e-commerce and permits firms such as Amazon India and Flipkart to work only as marketplaces for other businesses.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas